Электронный архив

Barnase and binase: Twins with distinct fates

Показать сокращенную информацию

dc.contributor.author Ulyanova V.
dc.contributor.author Vershinina V.
dc.contributor.author Ilinskaya O.
dc.date.accessioned 2018-09-18T20:24:29Z
dc.date.available 2018-09-18T20:24:29Z
dc.date.issued 2011
dc.identifier.issn 1742-464X
dc.identifier.uri https://dspace.kpfu.ru/xmlui/handle/net/139565
dc.description.abstract RNases are enzymes that cleave RNAs, resulting in remarkably diverse biological consequences. Many RNases are cytotoxic. In some cases, they attack selectively malignant cells triggering an apoptotic response. A number of eukaryotic and bacterial RNase-based strategies are being developed for use in anticancer and antiviral therapy. However, the physiological functions of these RNases are often poorly understood. This review focuses on the properties of the extracellular RNases from Bacillus amyloliquefaciens (barnase) and Bacillus intermedius (binase), the characteristics of their biosynthesis regulation and their physiological role, with an emphasis on the similarities and differences. Barnase and binase can be regarded as molecular twins according to their highly similar structure, physical-chemical and catalytic properties. Nevertheless, the 'life paths' of these enzymes are not the same, as their expression in bacteria is controlled by diverse signals. Binase is predominantly synthesized under phosphate starvation, whereas barnase production is strictly dependent on the multifunctional Spo0A regulator controlling sporulation, biofilm formation and cannibalism. Barnase and binase also have some distinctions in practical applications. Barnase was initially suggested to be useful in research and biotechnology as a tool for studying protein-protein interactions, for RNA elimination from biological samples, for affinity purification of RNase fusion proteins, for the development of cloning vectors and for sterility acquisition by transgenic plants. Binase, as later barnase, was tested for antiviral, antitumour and immunogenic effects. Both RNases have found their own niche in cancer research as a result of success in targeted delivery and selectivity towards tumour cells. A number of eukaryotic and bacterial RNase-based strategies are being developed for use in anticancer and antiviral therapy. However, the physiological functions of these RNases are often poorly understood. Barnase and binase can be regarded as molecular twins according to their highly similar structural, physical-chemical and catalytic properties. Nevertheless, their expression in bacteria is controlled by diverse signals. © 2011 FEBS.
dc.relation.ispartofseries FEBS Journal
dc.subject Bacillus
dc.subject bacterial RNases
dc.subject barnase
dc.subject binase
dc.subject biosynthesis
dc.subject cancer therapy
dc.subject cytotoxicity
dc.subject physiological role
dc.subject practical application
dc.subject RNase inhibitor
dc.title Barnase and binase: Twins with distinct fates
dc.type Article
dc.relation.ispartofseries-issue 19
dc.relation.ispartofseries-volume 278
dc.collection Публикации сотрудников КФУ
dc.relation.startpage 3633
dc.source.id SCOPUS1742464X-2011-278-19-SID80052965616


Файлы в этом документе

Данный элемент включен в следующие коллекции

  • Публикации сотрудников КФУ Scopus [24551]
    Коллекция содержит публикации сотрудников Казанского федерального (до 2010 года Казанского государственного) университета, проиндексированные в БД Scopus, начиная с 1970г.

Показать сокращенную информацию

Поиск в электронном архиве


Расширенный поиск

Просмотр

Моя учетная запись

Статистика